Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock

Chicago Capital accrued its involvement successful PROCEPT BioRobotics, bringing the presumption to 1.46% of its 13F reportable AUM

• Top holdings aft the filing:

  • Alphabet: $212.79 cardinal (5.7% of AUM)

  • Meta Platforms: $162.41 cardinal (4.4% of AUM)

  • Amazon: $153.49 cardinal (4.1% of AUM)

  • Nvidia: $136.76 cardinal (3.7% of AUM)

  • Taiwan Semiconductor Manufacturing: $132.37 cardinal (3.6% of AUM)

As of April 23, 2026, PROCEPT BioRobotics shares were priced astatine $24.24, down 56.5% implicit the past year, underperforming the S&P 500 by 91 percent points.

PROCEPT BioRobotics:

• Develops, manufactures, and sells the AquaBeam Robotic System and Aquablation therapy for minimally invasive urologic surgery, chiefly targeting benign prostatic hyperplasia (BPH).

• Generates gross done income of robotic systems, recurring consumables, and related services to healthcare providers.

• Serves hospitals, ambulatory country centers, and urology practices, with a superior absorption connected the U.S. marketplace and expanding planetary presence.

PROCEPT BioRobotics Corporation is simply a surgical robotics innovator specializing successful urology, focusing connected image-guided, minimally invasive solutions for benign prostatic hyperplasia. The institution leverages a recurring gross exemplary done strategy income and ongoing consumable usage, supporting a increasing installed basal successful the United States and prime planetary markets. This strategy positions PROCEPT BioRobotics to capitalize connected the increasing request for advanced, less-invasive urologic treatments.

PROCEPT BioRobotics banal is down 76% from its all-time acceptable successful 2024, and Chicago Capital is pouncing connected the discounted shares. The steadfast has bought PRCT shares successful 7 of the past 8 quarters arsenic the banal declined from $80 to $25. As an up-and-coming, but inactive unprofitable stock, volatility similar this is communal among aesculapian instrumentality and attraction companies arsenic they archetypal person to beryllium their efficacy and past physique a concern astir their treatment.